Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial

Transplantation

Volumn 94, Issue 5, 2012, Pages 492-498

  Krämer, Bernhard K ^a,b   Klinger, Marian ^c   Vítko, Štefan ^d   Glyda, MacIej ^e   Midtvedt, Karsten ^f   Stefoni, Sergio ^g   Citterio, Franco ^h   Pietruck, Frank ⁱ   Squifflet, Jean Paul ^j,k   Segoloni, Giuseppe ^l   Krüger, Bernd ^a,b   Sperschneider, Heide ^m   Banas, Bernhard ^b   Bäckman, Lars ⁿ   Weber, Markus ^o   Carmellini, Mario ^p   Perner, Ferenc ^q   Claesson, Kerstin ^r   Marcinkowski, Wojciech ^s,t   Ostrowski, Marek ^u   Senatorski, Grzegorz ^v   Nordström, Johan ^w   Salmela, Kaija ^x   more..

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^e Province Hospital   (Poland)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

ⁱ UNIVERSITY HOSPITAL ESSEN   (Germany)

^j CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^k UNIVERSITY OF LIÈGE   (Belgium)

^l MOLINETTE HOSPITAL   (Italy)

^m KfH Nierenzentrum Jena   (Germany)

ⁿ UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^o UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^p UNIVERSITY OF SIENA   (Italy)

^q SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^r MEDICAL PRODUCTS AGENCY   (Sweden)

^s MEDICAL UNIVERSITY OF SILESIA   (Poland)

^t Fresenius NephroCare   (Poland)

^u POMERANIAN MEDICAL UNIVERSITY   (Poland)

^v MEDICAL UNIVERSITY OF WARSAW   (Poland)

^w KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^x HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

more..

Author keywords

Immunosuppression; Long term; Renal transplant; Steroid; Tacrolimus

Indexed keywords

BASILIXIMAB; CREATININE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTHROPATHY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FRACTURE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INSULIN TREATMENT; INTENTION TO TREAT ANALYSIS; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OPEN STUDY; POPULATION RESEARCH; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT DURATION; TREATMENT RESPONSE; TREND STUDY;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADULT; ANTIBODIES, MONOCLONAL; BIOPSY; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RECOMBINANT FUSION PROTEINS; RISK ASSESSMENT; RISK FACTORS; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84866338720     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31825c1d6c     Document Type: Article

References (30)

1. Ansell BM. Overview of the side effects of corticosteroid therapy. Clin Exp Rheumatol 1991; 9(suppl 6): 19.
2. Saag KG, Koehnke R, Caldwell JR, et al. Low dose long-term corti-costeroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 1994; 96: 115.
3. Fellstrom B. Risk factors for and management of post-transplantation cardiovascular disease. Bio Drugs 2001; 15: 261.
4. Walsh LJ, Wong CA, Oborne J, et al. Adverse effects of oral corti-costeroids in relation to dose in patients with lung disease. Thorax 2001; 56: 279.
5. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with systemic and topical corticosteroids. J Intern Med 2005; 257: 374.
6. Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum 2006; 54: 628.
7. Wolfe F, Michaud K. The risk of myocardial infarction and pharma-cologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis. Arthritis Rheum 2008; 58: 2612.
8. Curtis JR, Westfall AO, Allison J, et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum 2006; 55: 420.
9. Hricik DE, O'Toole MA, Schulak JA, et al. Steroid-free immunosup-pression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993; 4: 1300.
10. Pascual J, Quereda C, Zamora J, et al. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transplantation 2004; 78: 1548.
11. Pascual J, Zamora J, Galeano C, et al. Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 2009: 1: CD005632.
12. Pascual J, Galeano C, Royuella A, et al. A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation. Transplantation 2010; 90: 343.
13. Knight SR, Morris PJ. Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. Transplantation 2010; 89: 1.
14. Knight SR, Morris PJ. Steroid avoidance or withdrawal in renal transplantation. Transplantation 2011; 91: e25.
15. Opelz G, Döhler B, Laux G, et al. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 2005; 5(4 pt 1): 720.
16. Kasiske BL, Chakkera HA, Louis TA, et al. A meta-analysis of im-munosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11: 1910.
17. Margreiter R. Efficacy and safety of tacrolimus compared with ciclos-porin microemulsionin renal transplantation:arandomised multicentre study. Lancet 2002; 359: 741.
18. Mayer AD. Chronic rejection and graft half-life: five-year follow-up of the European tacrolimus multicenter renal study. Transplant Proc 2002; 34: 1491.
19. Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562.
20. Mayer AD, Dmitrewski J, Squifflet J-P, et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection. Transplantation 1997; 64: 436.
21. Vincenti F, Jensik SC, Filo RS, et al. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 2002; 73: 775.
22. Montagnino G, Krämer BK, Arias M. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in kidney transplantation: twelve-month follow-up. Transplant Proc 2002; 34: 1635.
23. Pascual J, van Hooff JP, Salmela K, et al. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant. Transplantation 2006; 82: 55.
24. Rostaing L, Cantarovich D, Mourad G, et al. Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and dacli-zumab induction in renal transplantation. Transplantation 2005; 79: 807.
25. Vitko S, Klinger M, Salmela K, et al. Two corticosteroid-free regi-mensVtacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetilVin comparison with a standard triple regimen in renal transplantation: results of the ATLAS study. Transplantation 2005; 80: 1734.
26. Krämer BK, Klinger M, Wlodarczyk Z, et al. Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one-year observational results. Clin Transplant 2010; 24: E1.
27. Woodle ES, First MR, Pirsch J, et al. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose cortico-steroid therapy. Ann Surg 2008; 248: 564.
28. Briggs JD. Cardiovascular complications in renal transplantation. Nephrol Dial Transplant 2001; 16(suppl 6): 156.
29. Rike AH, Mogilishetty G, Alloway RR, et al. Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids. Clin Transplant 2008; 22: 229.
30. Levey AS, Bosch JP, Lewis JB, et al. A more accurate methodto estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461.